Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. - Wikidata - awgldk - TriplyDB

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

http://www.wikidata.org/entity/Q35916157

about

Direct dynamin-actin interactions regulate the actin cytoskeleton.Podocytes Charcot-Marie-Tooth disease and intracellular traffic Cell biology and pathology of podocytes Podocyte endocytosis in the regulation of the glomerular filtration barrier The function of endocytosis in podocytes Novel siRNA delivery system to target podocytes in vivo Establishment of protein delivery systems targeting podocytes Disruption of Myosin 1e promotes podocyte injury CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study Regulation of dynamin oligomerization in cells: the role of dynamin-actin interactions and its GTPase activity.Structure of the kidney slit diaphragm adapter protein CD2-associated protein as determined with electron microscopy.Podocyte biology and pathogenesis of kidney disease Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset.Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.Reduction of proteinuria through podocyte alkalinization.Toward the development of podocyte-specific drugs.The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.Proteinuria: an enzymatic disease of the podocyte?Enzymatic disease of the podocyte.The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria Myo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytes Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.Proteinuria: is it all in the foot?One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.Emerging role of autophagy in kidney function, diseases and aging Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.Dynamin-mediated Nephrin phosphorylation regulates glucose-stimulated insulin release in pancreatic beta cells.Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney.

P2860

Q24302210-CC4475B5-F5E9-4DE7-B9C4-4518DB771709 Q26766118-CBBE931D-B993-4995-89EC-A60E369D31DB Q26824841-16CDDFFC-A644-454F-BFDD-5A7ED4891CE6 Q26853664-56977BB8-20FB-4DE7-B431-28DE705E7B21 Q27004073-103A16B2-C758-45C7-9DA6-37DA94F3126E Q27006914-E52A0536-6E13-4040-B24C-95CB0B4F8C24 Q27333807-1405463C-822F-4DD1-AFD5-AC84D27A39A0 Q28474937-E0A5EF6B-61F1-41F7-BE15-D98936CBFA8F Q28509726-89484D20-CD90-47A5-B8B5-90DF8FE91D4E Q28572534-6F38A0A2-9C3E-400A-8620-716798D8D371 Q28729900-03F503D6-0FF3-4B5A-B42D-8E68C0144CCF Q30009415-DA4EC9D7-C68C-4112-B2D9-7A9986A9D800 Q30009462-2558A546-329F-4709-82DD-4C2906CC1BF4 Q30424169-EA0D058D-F8C0-44D2-AF0B-A30C353C4760 Q30530966-2E802B60-4345-45B5-90BE-DAEBFEBC0F70 Q33436829-EA019EFA-334F-4AE2-89CB-9FB684311FA6 Q33597457-8EED2830-6A63-4AD9-8858-F7C52E4C20C8 Q33634030-8271168D-E538-4D54-A4BC-2B317593BF81 Q33653550-E90B3F7E-52F8-49F4-95BB-96D7D8F2D573 Q33703811-0C7654FD-BC5B-403B-BFAA-8E9197C95604 Q33744759-F9383120-E039-49AF-8082-8D0FAEB4AF75 Q33792885-93EAAB71-7234-425D-858F-D7CC89211353 Q33872286-F6EBDE84-71A6-4C75-A07E-0D8F486E7526 Q33943247-2B0EE7BE-EA42-46E6-B40E-64984959F97B Q33943310-3CCCD5E8-9730-42AF-A104-BAEBC2871EA0 Q33943315-16BEB18F-022E-4B82-BF1C-B4AABC6DA434 Q33943376-7907F7D1-F1B0-4A90-8FD5-B289311F92D8 Q34001289-DCB9707A-3775-4AF9-8963-BBE3F7C5021C Q34211578-6B2A64CF-37D2-440E-8C89-DC38D961DD9D Q34476390-C1FAC527-DA47-4A42-A04F-96F056BFD03B Q34760971-EB7F4A7A-9554-4B15-8A35-D02CA07ED645 Q34974055-B688ABE6-688F-41F4-A37B-D95BA0BA7A3B Q35181072-EBEA2B1C-1B1A-490F-968A-0140554B6A9E Q35690375-1D7005C5-2A69-421F-8C06-278FDDA67E6D Q35916180-483E5D2E-EFED-4EDE-8857-10125603AD91 Q35990846-E6D2A526-C4F0-4D77-9233-DD33AAA1FCED Q36194753-D5885703-8181-4F32-BAC9-7E8CC488FF4F Q36195369-E78ECA8B-A567-4FD6-A8F5-E82FF9A260DF Q36217325-FD92FB51-292A-4E35-996D-7784595D7DB4 Q36494428-4F6AA759-CB1A-4E2B-8507-B8DE23A1BD0D

P2860

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.

http://www.wikidata.org/entity/Q35916157

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@ast

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@en

type

label

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@ast

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@en

prefLabel

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@ast

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@en

P1433

Q35916157-C8482D64-4A3B-4737-AB73-807FD84A2A73

P1476

Q35916157-EEAFDE84-8BF3-47CB-8BD9-6DBFDF8BF67F

P2093

Q35916157-16FC462B-8A36-4BF7-9D0C-238DC86423A8

Q35916157-22B15ED2-C0BC-4B13-9215-B280F1CA5134

Q35916157-2B9AFC21-A1FD-478A-A512-4D5D26A37211

Q35916157-345CB512-D0A2-4C8F-BA4C-44BA07B45E79

Q35916157-3912F019-BF8A-4DAA-9BD1-739F107F344E

Q35916157-3B6BF3C8-67A4-4884-8E8C-B194CC63B94C

Q35916157-45899CF4-0E2F-4B5F-9F93-27FF23237016

Q35916157-51F298DF-E368-4EA5-BB95-3F9789954394

Q35916157-5BA1C49F-09B5-4D1E-82CC-E2C973E7F630

Q35916157-73760775-2AA1-419F-BFAD-426BD78898C7

P2860

Q35916157-0AED7179-DA5A-4BF4-942F-5F756E37D4C5

Q35916157-0C554581-DA20-41F3-850E-885CC9B7428E

Q35916157-0EC9CA70-E47E-4C7D-8878-AE4B5C1035B1

Q35916157-151D7238-7BAE-4066-A2E5-DCB1F15D84B8

Q35916157-20CF419A-7B42-47A5-A4A1-00592A52977B

Q35916157-2C412BDA-AA5A-49CD-ABAE-6679D6515E4E

Q35916157-32C88715-5424-4CC2-BCA5-283C6EC31EED

Q35916157-34BD9EBF-2A2F-4783-8204-02048E035CC1

Q35916157-3A8F1F9F-4D5D-452E-A703-B43756A94B4C

Q35916157-4946B2CF-EBC3-4F81-AACC-E6F48427C631

P304

Q35916157-AFB2596E-9FC0-4609-97FC-F8BEE1BEF333

P31

Q35916157-B45D95D2-C774-440B-96B4-D08BCE67BE0E

P356

Q35916157-CA81DCC1-568B-43B4-9FD8-4C4BEBCE48CA

P407

Q35916157-46A424E0-5618-49B3-BD55-4B61BD0F4B33

P433

Q35916157-3E9216F9-F1ED-4A5C-B344-60BF7D2367A0

P478

Q35916157-BAB7C064-89B1-488E-B5A7-DA00EC027217

P50

Q35916157-E0257BA9-950C-41B6-BB6A-4260E1419C80

Q35916157-FDB896FD-2F5E-454C-B0C0-1680D1563E64

P577

Q35916157-B2317FED-85AD-4D7B-9E7E-C7D44C2F4EE0

P5875

Q35916157-2477CAA3-7A33-4D1F-9444-1A5458C64A25

P698

Q35916157-DED86589-5DE8-482D-8BE9-5A6E1F58F60E

P921

Q35916157-EA6680AB-CB4C-45D6-AB5A-56774B7CB673

P932

Q35916157-4CF9EC65-82B0-4A01-8BAD-E58477F47FAF

P356

P1433

Journal of Clinical Investigation

P1476

Proteolytic processing of dyna ...... or proteinuric kidney disease.

@en

P2093

Ann Erickson

http://www.w3.org/2001/XMLSchema#string

Boris Nikolic

http://www.w3.org/2001/XMLSchema#string

Changli Wei

http://www.w3.org/2001/XMLSchema#string

Clemens C Möller

http://www.w3.org/2001/XMLSchema#string

Clemens D Cohen

http://www.w3.org/2001/XMLSchema#string

David Ko

http://www.w3.org/2001/XMLSchema#string

Elizabetta C del Re

http://www.w3.org/2001/XMLSchema#string

Jochen Reiser

http://www.w3.org/2001/XMLSchema#string

Joel Henderson

http://www.w3.org/2001/XMLSchema#string

Lianne Hsing

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that dynamin-2 functions as a signal-transducing GTPase

CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility

Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats

A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor

Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus

Induction of mutant dynamin specifically blocks endocytic coated vesicle formation

Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization.

Regulating actin dynamics at membranes: a focus on dynamin.

Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.

Three ways to make a vesicle.

P304

2095-2104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI32022

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Rudensky

Dontscho Kerjaschki

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6166968

http://www.w3.org/2001/XMLSchema#string

P698

17671649

http://www.w3.org/2001/XMLSchema#string

P921

P932

1934589

http://www.w3.org/2001/XMLSchema#string